Products
Technological Innovation
1. Two-component in-situ hydrogel technology
(1) Schematic diagram of two-component delivery and in-situ gelation
During clinical use, reagent A (polyethylene glycol derivative solution) and reagent B (cross-linking agent solution) are mixed in equal volumes using a double-barrel mixing device and injected through a needle into the target body cavity, where a hydrogel is formed in situ.
(2) Schematic diagram of the controlled degradation and absorption of hydrogel in the body
2. Technical advantages
Programmable Curing and degradation rate
Ready-to-use PEG solution formulation
Safety:Biodegradable and absorbable
3. Clinical Application
Radiotherapy protection: effectively reducing the radiation dose to neighboring healthy organs
Contact Us
Telephone: 021-51592768
E-mail: cs@reunionmed.com
Address: Floor 2, Building 7, 1630 Yecheng Road, Jiading District, Shanghai
Scan QR Code